Back to Search
Start Over
Three Phase 3 Trials of Datopotamab Deruxtecan-Based Combinations Initiated in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer
- Source :
- Business Wire. October 30, 2024
- Publication Year :
- 2024
-
Abstract
- * TROPION-Lung10 is evaluating Daiichi Sankyo and AstraZeneca's datopotamab deruxtecan plus rilvegostomig as first-line treatment for advanced or metastatic nonsquamous NSCLC with high PD-L1 expression without actionable genomic alterations * [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Business Wire
- Publication Type :
- News
- Accession number :
- edsgcl.814154597